Clinical Trial Update: Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating POMx pomegranate concentrate for preventing experimental rhinovirus infection in the context of the common cold has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• POMx Pomegranate Concentrate (pomegranate concentrate)

Snippet

Sponsor: POM Wonderful LLC | Conditions: Common Cold | Phase 2 | Status: COMPLETED